146 related articles for article (PubMed ID: 2891081)
21. Release of beta-endorphin-immunoreactivity from rat pituitary and hypothalamus in vitro: effects of isoproterenol, dopamine, corticotropin-releasing factor and arginine8-vasopressin.
Sweep CG; Wiegant VM
Biochem Biophys Res Commun; 1989 May; 161(1):221-8. PubMed ID: 2525039
[TBL] [Abstract][Full Text] [Related]
22. Corticotropin-releasing hormone and dexamethasone do not alter secretion of immunoreactive beta-endorphin from dissociated fetal hypothalamic cell cultures.
Kapcala LP; Juang HH; Weng CF
Brain Res; 1990 Nov; 532(1-2):76-81. PubMed ID: 2282534
[TBL] [Abstract][Full Text] [Related]
23. Stimulation by corticotropin-releasing factor of the release of immunoreactive dynorphin A from mouse spinal cords in vitro.
Song ZH; Takemori AE
Eur J Pharmacol; 1992 Nov; 222(1):27-32. PubMed ID: 1361439
[TBL] [Abstract][Full Text] [Related]
24. Effect of endogenous opioid peptides on TRH release from rat stomach in vitro.
Mitsuma T; Hirooka Y; Nakada K; Nomura A; Nogimori T
Endocrinol Exp; 1989 Mar; 23(1):11-6. PubMed ID: 2565806
[TBL] [Abstract][Full Text] [Related]
25. CRF alters the infundibular LHRH secretory system from the medial preoptic area of female rats: possible involvement of opioid receptors.
Rivest S; Plotsky PM; Rivier C
Neuroendocrinology; 1993; 57(2):236-46. PubMed ID: 8389996
[TBL] [Abstract][Full Text] [Related]
26. Hypothalamic corticotropin-releasing hormone and opioid peptide neurons: functional changes after adrenalectomy and/or castration.
Almeida OF; Hassan AH; Harbuz MS; Linton EA; Lightman SL
Brain Res; 1992 Feb; 571(2):189-98. PubMed ID: 1351778
[TBL] [Abstract][Full Text] [Related]
27. Adrenalectomy and experimental hypercorticalism modulate the basal, corticotropin-releasing-hormone- and arginine-vasopressin-stimulated release of hypothalamic beta-endorphin.
Patchev VK; Racké K; Almeida OF
Neuroendocrinology; 1991 Aug; 54(2):111-7. PubMed ID: 1766548
[TBL] [Abstract][Full Text] [Related]
28. Progesterone-receptive beta-endorphin and dynorphin B neurons in the arcuate nucleus project to regions of high gonadotropin-releasing hormone neuron density in the ovine preoptic area.
Dufourny L; Caraty A; Clarke IJ; Robinson JE; Skinner DC
Neuroendocrinology; 2005; 81(3):139-49. PubMed ID: 15976512
[TBL] [Abstract][Full Text] [Related]
29. Regulation of lordosis behaviour in the female rat by corticotropin-releasing factor, beta-endorphin/corticotropin and luteinizing hormone-releasing hormone neuronal systems in the medial preoptic area.
Sirinathsinghji DJ
Brain Res; 1986 Jun; 375(1):49-56. PubMed ID: 3013371
[TBL] [Abstract][Full Text] [Related]
30. Hypothalamic opioid mechanisms in experimental uremic hypogonadism.
Dong QH; Handelsman DJ
Endocrinology; 1990 Mar; 126(3):1498-503. PubMed ID: 2137774
[TBL] [Abstract][Full Text] [Related]
31. Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides.
Iyengar S; Kim HS; Wood PL
Brain Res; 1987 Dec; 435(1-2):220-6. PubMed ID: 2892574
[TBL] [Abstract][Full Text] [Related]
32. Opiate receptor subtype regulation of CRF-41 release from rat hypothalamus in vitro.
Tsagarakis S; Rees LH; Besser M; Grossman A
Neuroendocrinology; 1990 May; 51(5):599-605. PubMed ID: 2162017
[TBL] [Abstract][Full Text] [Related]
33. In vitro regulation of immunoreactive beta-endorphin secretion from adult and fetal hypothalamus by sequential stimulation with corticotropin-releasing hormone.
Kapcala LP; Weng CF
Brain Res; 1992 Aug; 588(1):13-20. PubMed ID: 1327406
[TBL] [Abstract][Full Text] [Related]
34. In vitro effects of endogenous opiate peptides on thyrotropin function: inhibition of thyrotropin-releasing hormone release and absence of effect on thyrotropin release.
Jordan D; Veisseire M; Borson-Chazot F; Mornex R
Neurosci Lett; 1986 Jun; 67(3):289-94. PubMed ID: 2874532
[TBL] [Abstract][Full Text] [Related]
35. Opioids act centrally to modulate stress-induced decrease in luteinizing hormone in the rat.
Petraglia F; Vale W; Rivier C
Endocrinology; 1986 Dec; 119(6):2445-50. PubMed ID: 2877862
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the effects of acute ethanol administration on the release of beta-endorphin peptides by the rat hypothalamus.
Gianoulakis C
Eur J Pharmacol; 1990 May; 180(1):21-9. PubMed ID: 2142093
[TBL] [Abstract][Full Text] [Related]
37. Hypothalamic and suprahypothalamic effects of prolonged treatment with dexamethasone in the rat.
Calogero AE; Liapi C; Chrousos GP
J Endocrinol Invest; 1991 Apr; 14(4):277-86. PubMed ID: 1650804
[TBL] [Abstract][Full Text] [Related]
38. Modulation by Leu-enkephalin of peptide release from perifused neurointermediate pituitary. II. Inhibition of calcium-mediated secretion of alpha-MSH and beta-endorphin.
Al Zein M; Lutz-Bucher B; Koch B
Neuroendocrinology; 1986; 42(3):248-54. PubMed ID: 2936972
[TBL] [Abstract][Full Text] [Related]
39. Modulation of lordosis behaviour in the female rat by corticotropin releasing factor, beta-endorphin and gonadotropin releasing hormone in the mesencephalic central gray.
Sirinathsinghji DJ
Brain Res; 1985 Jun; 336(1):45-55. PubMed ID: 2860950
[TBL] [Abstract][Full Text] [Related]
40. Alterations in opioid parameters in the hypothalamus of rats with estradiol-induced polycystic ovarian disease.
Desjardins GC; Beaudet A; Brawer JR
Endocrinology; 1990 Dec; 127(6):2969-76. PubMed ID: 2174340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
